Home › Asset managers › Compare 2024-2025 › Dimensional vs Lincoln Financial
Dimensional 2024-2025 · Lincoln Financial 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 78,417 | 73,148 | 1,211 | 4,058 | 98.4% | 96.6% |
| Board proposals | 65,405 | 60,940 | 1,069 | 3,396 | 98.3% | 96.5% |
| E&S shareholder proposals | 255 | 125 | 0 | 130 | 100.0% | 87.4% |
| Other items | 12,757 | 12,083 | 142 | 532 | 98.8% | 97.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,211 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Dimensional | Lincoln Financial |
|---|---|---|---|---|---|---|
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CVRX INC. | June 3, 2025 | Election of Class I Directors: Mitch Hill Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Approval of an amendment to the Company's 2020 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Election of Directors: Allison M. Leopold Tilley Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Election of Directors: Philip Gregory Calhoun Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| DANSKE BANK A/S | March 20, 2025 | Approve Remuneration Policy Compensation |
Board | For | AGAINST 13 funds |
FOR 1 fund |
| DANSKE BANK A/S | March 20, 2025 | Reelect Martin Norkjaer Larsen as Director Director Elections |
Board | For | FOR 13 funds |
ABSTAIN 1 fund |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | December 31, 2024 | Approve Financing Proposal of Datang International as the Parent Company for the Year of 2025 Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | March 25, 2025 | Approve Centralized Registration of Non-Financial Corporate Debt Financing Instruments and Shelf Offering of Corporate Bonds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DEMANT A/S | March 6, 2025 | APPROVE REMUNERATION REPORT (ADVISORY VOTE) Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Approve Remuneration Report Compensation |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Elect Angela Titzrath to the Supervisory Board Director Elections |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Elect Astrid Stange to the Supervisory Board Director Elections |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Elect Erich Clementi to the Supervisory Board Director Elections |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DIANTHUS THERAPEUTICS INC. | May 22, 2025 | To approve, on an advisory basis, the compensation paid to our named executive officers; and Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DIANTHUS THERAPEUTICS INC. | May 22, 2025 | To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Marino Garcia Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| DIVERSIFIED HEALTHCARE TRUST | May 29, 2025 | Election of Trustees: Nominees (for Independent Trustee): Lisa Harris Jones Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| DIVERSIFIED HEALTHCARE TRUST | May 29, 2025 | Election of Trustees: Nominees (for Managing Trustee): Adam Portnoy Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| DIXON TECHNOLOGIES (INDIA) LTD. | September 25, 2024 | Approve Enhancement of the Limits of Inter-corporate Loans, Investments, Guarantee or Security and Acquisition Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| DOCGO INC. | June 17, 2025 | To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| DONG-E-E-JIAO CO. LTD. | May 20, 2025 | Approve Authorization of the Board to Handle All Related Matters Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DONG-E-E-JIAO CO. LTD. | May 20, 2025 | Approve Draft and Summary of Performance Shares Incentive Plan (Second Revision) Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DONG-E-E-JIAO CO. LTD. | May 20, 2025 | Approve Measures for the Administration of Performance Shares Incentive Plan (Revision) Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DONG-E-E-JIAO CO. LTD. | May 20, 2025 | Approve Methods to Assess the Performance of Plan Participants (Second Revision) Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DOOSAN BOBCAT INC. | March 26, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DOOSAN ENERBILITY CO. LTD. | March 31, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| DOUGLAS EMMETT INC. | May 29, 2025 | Election of Directors: Shirley Wang Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 3 funds |
| DOUGLAS EMMETT INC. | May 29, 2025 | To approve, in a non-binding advisory vote, our executive compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| EASTERLY GOVERNMENT PROPERTIES INC. | May 22, 2025 | Election of Directors: Cynthia A. Fisher Director Elections |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| ECOPRO BM CO. LTD. | March 25, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| ECOPRO CO. LTD. | March 26, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| ECOVACS ROBOTICS CO. LTD. | May 16, 2025 | Approve Application of Bank Credit Lines Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| ECOVACS ROBOTICS CO. LTD. | May 16, 2025 | Approve Provision of Guarantee Among Subsidiaries Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| ECOVACS ROBOTICS CO. LTD. | May 16, 2025 | Approve Provision of Guarantee for Wholly Owned Subsidiaries Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| EICHER MOTORS LTD. | August 22, 2024 | Reelect Govindarajan Balakrishnan as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| ELASTIC NV | October 1, 2024 | Appointment of the following executive director and non-executive directors, respectively, each for a term of three (3) years, ending at the close of the annual general meeting of 2027: Shay Banon Director Elections |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| ELISA OYJ | April 2, 2025 | Approve Remuneration Policy And Other Terms of Employment For Executive Management Compensation |
Board | For | AGAINST 13 funds |
FOR 1 fund |
| ELISA OYJ | April 2, 2025 | Approve Remuneration Report (Advisory Vote) Compensation |
Board | For | AGAINST 13 funds |
FOR 1 fund |
| EMERALD HOLDING INC. | May 21, 2025 | Election of Class II Directors: Lisa Klinger Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 1 fund |
| EMERALD HOLDING INC. | May 21, 2025 | Election of Class II Directors: Todd Hyatt Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 1 fund |
| ENCHEM CO. LTD. | March 31, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| ENCORE ENERGY CORP. | August 28, 2024 | Elect Director Susan Hoxie-Key Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| ENCORE ENERGY CORP. | June 11, 2025 | To elect eight directors for the ensuing year: Dennis E. Stover Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| ENCORE ENERGY CORP. | June 11, 2025 | To elect eight directors for the ensuing year: William M. Sheriff Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| ENERGY FUELS INC. | June 11, 2025 | Election of Directors: Benjamin Eshleman III Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| ENTRADA THERAPEUTICS INC. | June 11, 2025 | Election of Directors: Dipal Doshi Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 2 funds |
| ENTRADA THERAPEUTICS INC. | June 11, 2025 | Election of Directors: Mary Thistle Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 2 funds |
| EOPTOLINK TECHNOLOGY INC. LTD. | May 15, 2025 | Approve Application of Bank Credit Lines and Provision of Guarantee Capital Structure |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| ESCALADE INC. | May 6, 2025 | Election of Directors: Edward E. Williams Director Elections |
Board | For | FOR 19 funds |
WITHHOLD 1 fund |
| ESCALADE INC. | May 6, 2025 | Election of Directors: Walter P. Glazer, Jr. Director Elections |
Board | For | WITHHOLD 19 funds |
FOR 1 fund |
| ESCALADE INC. | May 6, 2025 | To approve, by non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 20 funds |
FOR 1 fund |
| EURAZEO SE | May 7, 2025 | Approve Compensation Report of Corporate Officers Compensation |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| EURAZEO SE | May 7, 2025 | Approve Compensation and Termination Package of Olivier Millet, Management Board Member Compensation |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| EXTREME NETWORKS INC. | November 14, 2024 | Advisory vote to approve our named executive officers compensation; Say-on-Pay |
Board | For | AGAINST 14 funds |
FOR 3 funds |
| EYEPOINT PHARMACEUTICALS INC. | June 18, 2025 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| FARMLAND PARTNERS INC. | May 6, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| FERROVIAL SE | April 24, 2025 | Reelect Bruno Vito Benito Di Leo Allen as Non-Executive Director Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| FLAT GLASS GROUP CO. LTD. | June 16, 2025 | Approve Provision of Guarantees for Its Potential Credit Facility and Related Transactions Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| FOMENTO ECONOMICO MEXICANO SAB DE CV | April 11, 2025 | ELECT ALEJANDRO BAILLERES GUAL AS DIRECTOR Director Elections |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| FORTUM OYJ | April 1, 2025 | Reelect Ralf Christian, Luisa Delgado, Jonas Gustavsson (Deputy Chair), Marita Niemela, Teppo Paavola, Mikael Silvennoinen (Chair), Johan Soderstrom and Vesa-Pekka Takala as Directors; Elect Stefanie Kesting as New Director; Director Elections |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| GANFENG LITHIUM GROUP CO. LTD. | November 25, 2024 | Approve Provision of Guarantees to a Controlled Subsidiary Capital Structure |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| GANFENG LITHIUM GROUP CO. LTD. | April 28, 2025 | Approve Provision of Guarantees to a Controlled Subsidiary Capital Structure |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| GANFENG LITHIUM GROUP CO. LTD. | April 28, 2025 | Elect Li Liangbin as Director Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| GANFENG LITHIUM GROUP CO. LTD. | June 25, 2025 | Approve Forecast Amount of External Guarantees Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| GCM GROSVENOR INC. | June 5, 2025 | Election of Directors: Angela Blanton Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 2 funds |
| GCM GROSVENOR INC. | June 5, 2025 | Election of Directors: Francesca Cornelli Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 2 funds |
| GCM GROSVENOR INC. | June 5, 2025 | Election of Directors: Samuel C. Scott III Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 2 funds |
| GD POWER DEVELOPMENT CO. LTD. | March 19, 2025 | Approve Provision of Financial Guarantee Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| GD POWER DEVELOPMENT CO. LTD. | May 13, 2025 | Approve Application of Financing Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| GD POWER DEVELOPMENT CO. LTD. | May 13, 2025 | Approve Application of Financing of Company from Financial Institutions Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| GECINA SA | April 17, 2025 | Ratify Appointment of Ouma Sananikone as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| GEM CO. LTD. | September 6, 2024 | Approve Authorization of the Board to Handle All Related Matters Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| GEM CO. LTD. | September 6, 2024 | Approve Draft and Summary of Performance Shares Incentive Plan Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| GEM CO. LTD. | September 6, 2024 | Approve Methods to Assess the Performance of Plan Participants Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| GEM CO. LTD. | May 19, 2025 | Approve Application of Credit Lines Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| GENERATION BIO CO. | June 4, 2025 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
← Previous Page 5 of 13 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.